Status:
RECRUITING
China Structural Ventricular Arrhythmias Registry
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborating Sponsors:
Renmin Hospital of Wuhan University
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Ventricular Arrythmia
Eligibility:
All Genders
Brief Summary
This is an observational, prospective, multi-center registry ,aiming at building a risk stratification for malignant structural ventricular arrhythmias. 2000 participants will be recruited from 10 cen...
Detailed Description
In China, the prevalence and risk factors of malignant ventricular arrhythmias remain unclear. In addition ,the mainstream treatment relies on implantable devices and medication.China Malignant Ventri...
Eligibility Criteria
Inclusion
- diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.
Exclusion
- none
Key Trial Info
Start Date :
October 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 24 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03821051
Start Date
October 24 2017
End Date
October 24 2027
Last Update
January 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China, 100037